Adherence status was categorized as persistence, switching (from one SSRI to another SSRI), and discontinuation. Persistence was determined based on the number of days' supply of the prescribed drug, with a minimum of 15 days to refill. Survival analyses using life-table survival curves and Cox...
Rates of switching to another SSRI were 51.2% for fluoxetine, 58.5%' for paroxetine, and 49.0% for sertraline. In these patients, switching tended to occur from the recommended minimum dose of the first SSRI (71.2%) and to the recommended minimum dose of the second SSRI (76.5%). ...
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized c
Separating out the diverse switching processes from one another could possibly increase performance limits with regard to reproducibility and power consumption2,5. A Pt-dispersed silicon oxide system as an anion-based or electronic memory has recently been reported to improve device performance2,9. 1...
2 Given that less than one-third of patients achieve remission with their first course of antidepressant pharmacotherapy,3,4 an estimated 10.8 million US residents may benefit from an alternative treatment each year. For these patients, most treatment guidelines recommend either switching to another ...
A complementary approach that focuses on response to treatment in an individualized manner is one that uses the Goal Attainment Scale (GAS), developed by Kiresuk and Sherman in 1968 [7]. This scale uses a semiquantitative approach incorporating a patient’s individual expectations from treatment ...
Enrolled patients were either initiating or undergoing the first switch to an antidepressant monotherapy. Baseline data on patients’ clinical status, functioning, productivity, quality of life and medical-resource use were compared in a cross-sectional baseline analysis. Results A total of 1402 ...
pmh19 economic assessment of second-line treatment: switching from a generic ssri to escitalopram, an snri, or another generic ssri by patients with major depressive disorder (mdd)-pmh19经济评估的第二线治疗:开关从一个普通的SSRI,SNRI,艾司西酞普兰或其他通用SSRI患者重度抑郁症(MDD)-知来论文发表中心...
Switching to another SSRI or to venla- faxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA 2008;299:901-913.Brent, D., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M., ...
Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.DuloxetineSwitchingSSRISafetyApproximately half of all treated depressed patients fail to show adequate response to their initially prescribed antidepressant medication. Switching to another medication represents one possible...